Director/PDMR Shareholding

RNS Number : 3113V

Epistem Holdings plc

10 January 2012

 



Company               Epistem Plc

TIDM                     EHP.L (AIM)

Headline                Directors' Shareholdings

Released                        10^th January 2012

Number                

 Epistem Holdings Plc ("Epistem" or the "Company")

Directors' Shareholdings & AGM

Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009

As a result of the subscription for Partnership Shares and the award of Matching Shares, the executive Directors each increased their beneficial interests in the Company by 297 ordinary shares of 1.5p each. These shares were acquired on 2 November 2011, 9 November 2011 and 23 December 2011 at prices of 383p, 383pand 358p respectively.

Following these transactions, the current beneficial interests of the executive Directors are set out below:

Matthew Walls                             8,965                                   (0.10%)

Dr Catherine Booth                  983,320                                  (11.12%)

Dr Jeffrey Moore                        15,645                                   (0.18%)          

John Rylands                            193,218                                   (2.18%)

Epistem further announces that all resolutions proposed at the Annual General Meeting held on 14 December 2011 were passed.

For further details please contact:

Epistem Plc

Matthew Walls, CEO                                                               [phone]

John Rylands, Finance Director                                                 [phone]

Peel Hunt LLP

James Steel / Vijay Barathan                                                     [phone]

 

END

 

 

RDSBXGDBIBBBGDG